Our previous study found that dysregulated T cells, caused by low B-cell leukemia/lymphoma 11B (BCL11B) expression, are associated with the prognosis of MDS; however, the effect of abnormal IC receptor expression on NK cells on the clinical outcomes of MDS patients remains unclear [29]. The gene discussed is BCL11B; the disease is myelodysplastic syndrome.